Form D · Other
Atlas Labs, Inc.
Seattle, WA · CIK 0001790561
Offering snapshot reported Jan 26, 2022 · SEC filing
- Reported sold
- $41.5M Offering amount: $41.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 26, 2022 | Initial | $41,499,962 | No comparison | 15 | SEC filing |
| Oct 17, 2019 | Initial | $2,756,938 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430876
Includes $1,500,000 in convertible promissory notes ("Notes") and the underlying shares of equity issuable upon conversion of the Notes.
Conversion of promissory notes
Source: Form D, filed Jan 26, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ethan Davidoff | Executive |
| Elias Manousos | Director |
| Sundeep Peechu | Director |
Issuer details
Industry: Other (See others in industry)
Address:
111 Terry Ave. North Suite 3809
Seattle, WA, 98109
Seattle, WA, 98109